Association of Angiotensin Converting Enzyme (insertion\deletion) and Angiotensin II Type 1 Receptor (A1166C) gene polymorphisms with diabetic nephropathy in Iraqi type 2 diabetic patients
DOI:
https://doi.org/10.31351/vol33iss3pp17-29Abstract
Renin-angiotensin-aldosterone system abnormalities are the most prevalent cause of renal hemodynamic abnormalities, and candidate genes in this system are involved in the etiology of diabetic nephropathy (DN). A polymorphism in the angiotensin converting enzyme (ACE) gene I(insertion)\D(deletion) has been correlated to plasma ACE levels. Furthermore, the Angiotensin II Type 1 Receptor AGT1R (A1166C) expression pattern is highly related to nephropathy. The objectives of this study involved evaluating the frequency of the ACE (I/D) and AGT1R (A1166C) gene polymorphisms and investigating the association of these polymorphism with the development of DN in Iraqi patients with Type 2 diabetes mellitus (T2DM) and evaluating the levels of several urinary and serum markers in relation to studied polymorphisms. This is a cross-sectional study that included 161 T2DM patients whom were divided into two groups: T2DM with DN(included 98 patients) and normalbuminuric T2DM (included 63 patients). ACE gene polymorphism analysis revealed that the D allele was far more prevalent in DN patients compared to normalbuminuric patients (60.2% vs. 50.8%), while the I allele frequency was 39.8% in DN and 49.2% in normoalbuminuric patients. In addition, DN patients carrying the DD genotype had higher serum kidney injury molecule 1 (KIM1), serum cystatin C (CysC), and HbA1C and lower glomerular filtration rate (GFR) compared to ID+II genotypes. For AGT1R (A1166C), both DN and normalbuminuric patients had a comparable high prevalence of the AA genotype, followed by the AC genotype, while the CC genotype had been seen only in 3 patients. In conclusion, among the studied T2DM patients, individuals with DD genotype had higher frequency of DN and had 2-fold risk for DN compared to II genotype which had the lowest risk for DN. Also the current study shows that the A1166C polymorphisms of AGT1R distribution frequency were similar for both study groups with higher frequency for A allele compared to C allele and not associated with risk of DN in Iraqi T2DM
Keywords: Angiotensin Converting Enzyme (I\D) gene polymorphism, Angiotensin II Type 1 Receptor (A166C) gene polymorphisms, Cystatin C, Diabetic nephropathy, Kidney injury molecule1.
Received 27/5/2023
Accepted 26/7/2023
Published 15/9/2024
How to Cite
Publication Dates
References
Ahmed MH, Haddad NI, Nori E. Correlation between Albuminuria Levels and Chitinase 3 like 1 Protein in Iraqi Patients with Type 2 Diabetes Mellitus. Iraqi Journal of Science. 2022:21-32.
Hamid GS, Allawi AA, Ghudhaib KK. Correlation of pentosidine with kidney diseases in Iraqi patients with diabetic nephropathy. Iraqi Journal of Science. 2021:3436-42.
Ali AA, Al Lami FH. Prevalence and determinants of microalbuminurea among type 2 diabetes mellitus patients, Baghdad, Iraq, 2013. Saudi Journal of Kidney Diseases and Transplantation. 2016;27(2):348-55.
Giacchetti G, Sechi LA, Rilli S, Carey RM. The renin–angiotensin–aldosterone system, glucose metabolism and diabetes. Trends in Endocrinology & Metabolism. 2005;16(3):120-6.
Salih B, Ali S, Allehibi K. Serum Aldosterone Levels in Patients With Diabetic Nephropathy in Relation to Vascular Calcification. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512). 2019;28:53-63.
Ilić V, Ilić M, Soldatović I, Popović S, Magić Z. Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus. Vojnosanitetski pregled. 2014;71(7).
Al-Radeef MY, Fawzi HA, Allawi AA. ACE gene polymorphism and its association with serum erythropoietin and hemoglobin in Iraqi hemodialysis patients. The Application of Clinical Genetics. 2019:107-12.
Su SL, Lu KC, Lin YF, Hsu YJ, Lee PY, Yang HY, et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2012;13(1):148-54.
Dhumad MM, Hamdan FB, Al-Mayah QS. Angiotensin-converting enzyme insertion/deletion (I/D) gene polymorphism in Iraqi type 2 diabetic patients: association with the risk of cardiac autonomic neuropathy. Egyptian Journal of Medical Human Genetics. 2020;21(1):1-7.
Ha S-K. ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information. Journal of diabetes research. 2014;2014.
Moner AIM, Wisam HS, Abdulrahmahman AO, Abdulameer MG, Salwa JA-A. Genotype Distribution of Angiotensin I- Converting Enzyme in Iraqi Arab Population Iraqi Journal of Cancer and Medical Genetics 2011;4(2):24-9.
Wong C, Kanetsky P, Raj D. Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatric Nephrology. 2008;23:1037-51.
Hussein MA, Al-Janabi LM, Algenabi AHA. Angiotensin converting enzyme (ace) gene polymorphism and the risk of diabetic nephropathy in type 2 diabetes. J Dent Med Sci. 2015;14(2):62-7.
Zhuang Y, Niu F, Liu D, Sun J, Zhang X, Zhang J, et al. Association between AGTR1 A1166C polymorphism and the susceptibility to diabetic nephropathy: Evidence from a meta-analysis. Medicine. 2018;97(41):e07689.
Chen Z, Wu H, Wang G, Feng Y. Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile. BMC nephrology. 2016;17:1-8.
Ibrahim R, Ghudhaib K, Allawi A. Determining ACE-2 Level and Some Relevant Biochemical Parameters and studying the effect of Gender in Iraqi Diabetic Patients with Glomeruli and Renal Tubules Fibrosis as Early Prediction Marker. Baghdad Science Journal. 2023.
Jin Y, Kuznetsova T, Thijs L, Schmitz B, Liu Y, Asayama K, et al. Association of left ventricular mass with the AGTR1 A1166C polymorphism. American journal of hypertension. 2012;25(4):472-8.
Braliou GG, Grigoriadou A-MG, Kontou PI, Bagos PG. The role of genetic polymorphisms of the Renin–Angiotensin System in renal diseases: A meta-analysis. Computational and structural biotechnology journal. 2014;10(16):1-7.
Yin X, Li H, Xuan J, Chen Y, Li L, Dong X. AGTR1 A1166C polymorphism is associated with risk of diabetic nephropathy. Zhejiang da xue xue bao Yi xue ban= Journal of Zhejiang University Medical Sciences. 2013;42(1):45-51.
Doria A, Onuma T, Warram J, Krolewski A. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia. 1997;40:1293-9.
Gallego PH, Shephard N, Bulsara MK, van Bockxmeer FM, Powell BL, Beilby JP, et al. Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus. Journal of Diabetes and its Complications. 2008;22(3):191-8.
Van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, Smulders Y, et al. Genetic polymorphisms of the renin–angiotensin system and complications of insulin‐dependent diabetes mellitus. Nephrology Dialysis Transplantation. 2000;15(7):1000-7.
Sahan KA, Aziz IH. Polymorphism of Angiotensin Type 1 Receptor Gene (SNP rs5186 A1166C) Related with Hypertension Patients in Baghdad. Iraqi journal of biotechnology. 2018;17(3).
Ghafil FA, Mohammad BI, Al-Janabi HS, Hadi NR, Al-Aubaidy HA. Genetic Polymorphism of Angiotensin II Type 1 Receptors and Their Effect on the Clinical Outcome of Captopril Treatment in Arab Iraqi Patients with Acute Coronary Syndrome (Mid Euphrates). Indian journal of clinical biochemistry : IJCB. 2021;36(1):81-7.
Osman WM, Jelinek HF, Tay GK, Khandoker AH, Khalaf K, Almahmeed W, et al. Clinical and genetic associations of renal function and diabetic kidney disease in the United Arab Emirates: a cross-sectional study. BMJ open. 2018;8(12):e020759.
MANUFACTURER:, SAS B. CREATININE Kinetic method. France. [Internet].
abnova. BCG Albumin Assay Kit. [Internet]. Available from: https://www. abnova. com/products/products_detail.asp?catalog_id=KA1612.
Nathan Levin M. [Available from: https://www.kidney.org/professionals/kdoqi/gfr_calculatorNathan.
Alp E, Menevşe S. Comparison of conventional and real time PCR methods to determine of the ace I/D and angiotensinogen m235t polymorphisms. Marmara Medical Journal. 2009;22(1):27-33.
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K, et al. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA and cell biology. 2009;28(3):141-50.
Yong Y, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell research. 2005;15(2):97.
Nikzamir A, Nakhjavani M, Golmohammadi T, Dibai L, Saffary R. Polymorphism in the angiotensin-converting enzyme (ACE) gene and ACE activity in type 2 diabetic patients. Acta Medica Iranica. 2008:277-82.
Ding W, Wang F, Fang Q, Zhang M, Chen J, Gu Y. Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis. Molecular biology reports. 2012;39:1293-303.
Mizuiri S, Hemmi H, Kumanomidou H, Iwamoto M, Miyagi M, Sakai K, et al. Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney international. 2001;60(3):1124-30.
Zeng W-l, Yang S-k, Song N, Chu F-f. The impact of angiotensin converting enzyme insertion/deletion gene polymorphism on diabetic kidney disease: A debatable issue. nefrologia. 2022;42(4):415-31.
Kadhim NE, Hoidy WH. Association of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism with Diabetic Nephropathy Patients: a Case-Control Study. HIV Nursing. 2022;22(2):1589–92-–92.
Freitas SR, Cabello PH, Moura-Neto RS, Dolinsky LC, Lima AB, Barros M, et al. Analysis of renin-angiotensin-aldosterone system gene polymorphisms in resistant hypertension. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2007;40(3):309-16.
Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY. Identification of specific angiotensin‐converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes/metabolism research and reviews. 2009;25(8):717-24.
AAdS R, EGd S, KdF S, LRBd A, RdS S, Freiria-Oliveira A. Do ACE and ACE2 Polymorphisms Influence in the Pathogenesis of Diabetic Nephropathy? 2021.
Taha MM, Mahdy-Abdallah H, Shahy EM, Helmy MA, ElLaithy LS. Diagnostic efficacy of cystatin-c in association with different ACE genes predicting renal insufficiency in T2DM. Scientific Reports. 2023;13(1):5288.
Shah VN, Cheema BS, Sharma R, Khullar M, Kohli HS, Ahluwalia TS, et al. ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes. Molecular and cellular biochemistry. 2013;372(1-2):191-8.
Ribeiro-Oliveira Jr A, Nogueira AI, Pereira RM, Boas WWV, Dos Santos RAS, e Silva ACS. The renin–angiotensin system and diabetes: an update. Vascular health and risk management. 2008;4(4):787-803.
Razi F, Daneshpour MS, Karimoei M, Mehrabzadeh M, Bandarian F, Bahreini E, et al. AGTR1 rs5186 variants in patients with type 2 diabetes mellitus and nephropathy. Meta Gene. 2018;15:50-4.
Halder K, Purkait P. Association of Angiotensin II Type I Receptor (AGTR1) Gene Polymorphism and Type 2 Diabetes & Nephropathy among the Eastern Indian Bengali Patients. Diabetes Obes Int J Diabetes Obes Int J. 2020;5(2):1-13.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal of Pharmaceutical Sciences( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
